HDAC4 / HDAC5 / HDAC9 (phospho Ser246 / Ser259 / Ser220) Antibody

• Catalog Number: orb1253696
• Category: Antibodies
• Description: HDAC4 / HDAC5 / HDAC9 (phospho Ser246 / Ser259 / Ser220) Antibody
• Target: HDAC4 HDAC5 HDAC9
• Clonality: Polyclonal
• Conjugation: Unconjugated
• Reactivity: Human
• Form/Appearance: Liquid
• Concentration: 1 mg/mL
• Buffer/Preservatives: Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
• Purification: Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
• Immunogen: HDAC4/HDAC5/HDAC9 (phospho-Ser246/259/220) antibody was raised against a peptide sequence around phosphorylation site of serine 246/259/220 (T-A-S (p) -EP) derived from Human HDAC4/HDAC5/HDAC9.
• UniProt ID: P56524, Q9UQL6, Q9UKV0
• MW: 140, 124 kDa
• Tested applications: IHC, WB
• Application notes: Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100
• Antibody Type: Primary Antibody
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Alternative names: HD4, AHO3, BDMR, HDACA, HA6116, HDAC-4, HDAC-A, CY
• Note: For research use only
• NCBI: NP_001015053.1, NP_055522.1, NP_006028.2

Western blot analysis of lysed extracts from 293 cells untreated or treated with EGF using HDAC4/HDAC5/HDAC9 (phospho-Ser246/259/220).

Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using HDAC4/HDAC5/HDAC9 (Phospho-Ser246/259/220).